… for patients treated with hydroxychloroquine. However, delirium is expected to be a more likely
etiology of neuropsychiatric symptoms in critically ill patients treated … , clinical features that …

… To search for cases that were associated with chloroquine (including hydroxychloroquine)
or mefloquine treatment and presented with any of the AEs of interest, we used the following …

… of the risk of suicide with hydroxychloroquine for patients with COVID-19, … clinical
manifestations during hydroxychloroquine treatment have already been reported but in the treatment …

… COVID-19 clinical presentation primarily affects the … neurologic manifestations reported in
patients with mild symptoms … (CQ), hydroxychloroquine (HCQ) and lopinavir/ritonavir treatment, …

… adverse neuropsychiatric effects such as delirium have been rarely reported in adults [6]. …
These treatments are able to induce neuropsychiatric symptoms from mild (mood lability, …

… the use of chloroquine and hydroxychloroquine for treatment and prevention of coronavirus
… which 520 (12.0%) reported neuropsychiatric adverse events. Exposure to chloroquine was …

… risk such as the Malaria or other medical conditions effects versus drug effects in patients,
the prophylaxis versus treatment and the underlying neuropsychiatric risk. We can predict that …

… One study reported that 9.4% of patients developed neuropsychiatric symptoms, while …
tissues of elderly patients due to diminished body hydration. Therefore, symptoms may be present …

… of neuropsychiatric problems with the use of common antimalarials in a population of …
reported happened in individuals without a history of psychiatric diseases. Elderly patients are at …

… patients with autoimmune diseases and COVID-19. A broad spectrum of neuropsychiatric
adverse effects affected patients treated … in COVID-19 patients. Gastrointestinal adverse effects …